First Time Loading...

Legend Biotech Corp
NASDAQ:LEGN

Watchlist Manager
Legend Biotech Corp Logo
Legend Biotech Corp
NASDAQ:LEGN
Watchlist
Price: 42.6 USD -0.14% Market Closed
Updated: May 23, 2024

Legend Biotech Corp
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Legend Biotech Corp
Total Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Legend Biotech Corp
NASDAQ:LEGN
Total Liabilities
$597.2m
CAGR 3-Years
69%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Liabilities
$140.9B
CAGR 3-Years
1%
CAGR 5-Years
17%
CAGR 10-Years
19%
Gilead Sciences Inc
NASDAQ:GILD
Total Liabilities
$38.8B
CAGR 3-Years
-7%
CAGR 5-Years
-1%
CAGR 10-Years
10%
Amgen Inc
NASDAQ:AMGN
Total Liabilities
$88B
CAGR 3-Years
18%
CAGR 5-Years
11%
CAGR 10-Years
7%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Liabilities
$5.4B
CAGR 3-Years
20%
CAGR 5-Years
24%
CAGR 10-Years
19%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Liabilities
$7.4B
CAGR 3-Years
8%
CAGR 5-Years
17%
CAGR 10-Years
22%

See Also

What is Legend Biotech Corp's Total Liabilities?
Total Liabilities
597.2m USD

Based on the financial report for Dec 31, 2023, Legend Biotech Corp's Total Liabilities amounts to 597.2m USD.

What is Legend Biotech Corp's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
7%

Over the last year, the Total Liabilities growth was 2%. The average annual Total Liabilities growth rates for Legend Biotech Corp have been 69% over the past three years , 7% over the past five years .